Aflac Incorporated
Aflac Incorporated (AFL) Stock Overview
Explore Aflac Incorporated’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
56B
P/E Ratio
15.71
EPS (TTM)
$6.43
ROE
0.14%
AFL Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Aflac Incorporated (AFL) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $133.48.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 15.71 and a market capitalization of 56B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.
Analyst Recommendations
Price Targets
Company Profile
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates through two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care income support, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan. The Aflac U.S. segment provides cancer, accident, short-term disability, critical illness, hospital indemnity, dental, vision, long-term care and disability, and term and whole life insurance products in the United States. It sells its products through sales associates, brokers, independent corporate agencies, individual agencies, and affiliated corporate agencies. The company was founded in 1955 and is based in Columbus, Georgia.
Daniel Paul Amos
12,694
1932 Wynnton Road, Columbus, GA
1980